Facts & Take Action


  • Ovarian Cancer is the fifth leading cause of death among women in the United States and is the most deadly of all gynecologic cancers.
  • Ovarian Cancer is not an uncommon disease occurring in 1 of every 71 women.
  • When ovarian cancer is detected early, before it has spread beyond the ovaries, more than 90% of women will survive longer than five years. Only 19% of women are diagnosed in the early stages.
  • Currently, 50% of women diagnosed with ovarian cancer die from the disease within five years. When diagnosed in advanced stages, the chance of five- year survival is only 44%.
  • Ovarian cancer is often difficult to diagnose because symptoms may be subtle, are easily confused with other diseases and because there is no single reliable easy-to-administer screening tool.
  • A woman can get Ovarian Cancer even if her ovaries have been removed.



  • Women who have these symptoms almost daily for more than a few weeks should see their doctor, preferably a gynecologist.
  • Experts recommend a pelvic/rectal exam, a transvaginal sonogram, and a CA 125 blood test. A Pap test does not detect ovarian cancer.
  • While most early ovarian tumors are difficult for even the most skilled doctor to feel during a pelvic exam, an exam may help identify other cancers or gynecologic conditions. Discuss the need for these exams with your doctor.

If ovarian cancer is suspected, it is crucial to see a gynecologic oncologist who specializes in women’s cancers. Prompt medical evaluation may lead to detection at the earliest possible stage of the disease. Early stage diagnosis is associated with an improved prognosis.

OVA1 is an FDA cleared blood test that can help a physician evaluate an ovarian mass for the risk of malignancy prior to a planned surgery. Women with a higher risk may benefit from being referred to gynecologic oncologist for surgery and following treatment. OVA1 is indicated for women over the age of 18, with an ovarian mass who have not been referred to a specialist. It is not intended to be a screening test or to determine whether a patient should proceed to surgery. For more information please visit www.ova-1.com